Avoro Capital Advisors LLC acquired a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,000,000 shares of the company’s stock, valued at approximately $66,950,000. Mind Medicine (MindMed) accounts for about 0.7% of Avoro Capital Advisors LLC’s investment portfolio, making the stock its 22nd biggest position.
A number of other hedge funds also recently modified their holdings of MNMD. ExodusPoint Capital Management LP acquired a new stake in shares of Mind Medicine (MindMed) during the 4th quarter worth about $254,000. Marex Group plc acquired a new stake in shares of Mind Medicine (MindMed) during the 4th quarter worth about $268,000. EntryPoint Capital LLC acquired a new stake in shares of Mind Medicine (MindMed) during the 4th quarter worth about $271,000. Concurrent Investment Advisors LLC acquired a new stake in shares of Mind Medicine (MindMed) during the 4th quarter worth about $273,000. Finally, PSP Research LLC acquired a new stake in shares of Mind Medicine (MindMed) during the 4th quarter worth about $467,000.
Mind Medicine (MindMed) Stock Performance
NASDAQ MNMD opened at $0.69 on Wednesday. The business’s 50-day moving average price is $0.69.
Mind Medicine (MindMed) (NASDAQ: MNMD) is a clinical-stage biotechnology company focused on developing psychedelic-inspired medicines and accompanying therapeutic protocols to treat mental health disorders and substance use disorders. The company’s research emphasizes both novel small molecules and established psychedelic compounds used in controlled, clinically supervised settings, with the goal of creating safe, scalable treatments that combine pharmacology with psychotherapy.
MindMed’s activities include preclinical research, clinical trials, and the development of treatment delivery models and protocols that integrate drug administration with therapeutic support.
See Also
- Five stocks we like better than Mind Medicine (MindMed)
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding MNMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report).
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
